The Government will Support Pharmaceutical Manufacturers
The Government has approved the anticrisis plan. On March, 1 at the website of the Russian Government a corresponding document was placed: “Russian Government Action Plan to Ensure Stable Social-Economical Development of the Russian Federation in 2016”. Its priority is to support the quality of life of Russian citizens, social obligations of the state.
An explanatory note says that the key area of efforts of the Russian Government will be to implement structural measures to diversify the economy and create conditions for sustainable economic growth in the mid-term perspective. Measures, aimed at prevention of irreversible crisis in the economy sectors significant from the point of view of food safety and social stability, including drug circulation.
Tools ensuring improvement of business conduction and regulatory medium conditions, support of small and mid-sized entrepreneurship, import substitution, export of non-resource products.
The plan envisages support of local manufacturers of drugs of lower price segment by subsidies for financing part of expenses, related to manufacture of vital and essential drugs, as well as development of special order of price readjustment.
As a result, it is expected to lower the risk of wash-out of drugs below 50 rubles and maintenance of portfolio availability of drugs for population.
The plan envisages follow-up capitalization of the Industry Development Fund, as a result it will sponsor at least 50 projects aimed at development of manufacture of import substitution products.
It is also suggested to approve roadmaps of the National Technological Initiative aimed at stimulation of development of Russian innovation companies, including pharma companies.